Cargando…

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

BACKGROUND: Drug-resistant minority variants (DRMinVs) detected in patients who recently acquired human immunodeficiency virus type 1 (HIV-1) can be transmitted, generated de novo through virus replication, or technical errors. The first form is likely to persist and result in treatment failure, whi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbisa, Jean L, Kirwan, Peter, Tostevin, Anna, Ledesma, Juan, Bibby, David F, Brown, Alison, Myers, Richard, Hassan, Amin S, Murphy, Gary, Asboe, David, Pozniak, Anton, Kirk, Stuart, Gill, O Noel, Sabin, Caroline, Delpech, Valerie, Dunn, David T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743824/ https://www.ncbi.nlm.nih.gov/pubmed/30534981 http://dx.doi.org/10.1093/cid/ciy1048

Ejemplares similares

Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK
por: Mbisa, Jean L, et al.
Publicado: (2020)

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data
por: Stirrup, Oliver T., et al.
Publicado: (2018)

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation
por: Stirrup, OT, et al.
Publicado: (2020)

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2016)

HIV-1 Transmission Patterns in Men Who Have Sex with Men: Insights from Genetic Source Attribution Analysis
por: Le Vu, Stéphane, et al.
Publicado: (2019)

Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control
por: Volz, Erik M, et al.
Publicado: (2018)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Efficient and unbiased metagenomic recovery of RNA virus genomes from human plasma samples
por: Manso, Carmen F., et al.
Publicado: (2017)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
por: Geretti, Anna Maria, et al.
Publicado: (2019)

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors
por: Kayondo, Jonathan K., et al.
Publicado: (2015)

Transmitted antiretroviral drug resistance in treatment naïve HIV-infected persons in London in 2011 to 2013
por: McFaul, Katie, et al.
Publicado: (2014)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
por: White, Ellen, et al.
Publicado: (2016)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
por: Stirrup, Oliver T, et al.
Publicado: (2019)

Extending Bayesian back-calculation to estimate age and time specific HIV incidence
por: Brizzi, Francesco, et al.
Publicado: (2019)

Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study
por: Brizzi, Francesco, et al.
Publicado: (2021)

Enhanced Detection of DNA Viruses in the Cerebrospinal Fluid of Encephalitis Patients Using Metagenomic Next-Generation Sequencing
por: Manso, Carmen F., et al.
Publicado: (2020)

Automated analysis of phylogenetic clusters
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2013)

Electronic health records to capture primary outcome measures: two case studies in HIV prevention research
por: Dunn, David, et al.
Publicado: (2023)

Re‐assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing
por: Kirwan, Peter D., et al.
Publicado: (2022)

Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019
por: Saunders, John, et al.
Publicado: (2021)

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
por: Marcus, Nufar, et al.
Publicado: (2021)

Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?
por: Brown, Alison E, et al.
Publicado: (2017)

First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines
por: El Bouzidi, Kate, et al.
Publicado: (2020)

Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya
por: Hassan, Amin S., et al.
Publicado: (2019)

Variation in the skulls of Elgaria and Gerrhonotus (Anguidae, Gerrhonotinae) and implications for phylogenetics and fossil identification
por: Ledesma, David T., et al.
Publicado: (2021)

Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom
por: Tostevin, A, et al.
Publicado: (2016)

Defining linkage to care following human immunodeficiency virus (HIV) diagnosis for public health monitoring in Europe
por: Croxford, Sara, et al.
Publicado: (2018)

An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
por: Smit, Erasmus, et al.
Publicado: (2017)

Editorial: minor stroke is not minor
por: Leng, Xinyi, et al.
Publicado: (2022)

Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway
por: Manso, Carmen F., et al.
Publicado: (2020)

The menopause transition in women living with HIV: current evidence and future avenues of research
por: Tariq, Shema, et al.
Publicado: (2016)

Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom
por: Samman, A., et al.
Publicado: (2011)

Phylogenetic Analysis of Human Immunodeficiency Virus Type 2 Group B
por: Cella, Eleonora, et al.
Publicado: (2016)

Current experiences of accessing and using HIV pre-exposure prophylaxis (PrEP) in the United Kingdom: a cross-sectional online survey, May to July 2019
por: O’Halloran, Charlotte, et al.
Publicado: (2019)

Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model
por: Presanis, Anne M, et al.
Publicado: (2021)

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

Jumps and Cojumps analyses of major and minor cryptocurrencies
por: Phiromswad, Piyachart, et al.
Publicado: (2021)

Association between rectal gonorrhoea and HIV incidence in men who have sex with men: a meta-analysis
por: Donnell, Deborah, et al.
Publicado: (2022)

Trends in HIV incidence between 2013–2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study
por: Hanum, Nadia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0d10dgpnpmvgfalpgklvmnq11f